Pesquisar
60 Degrees Pharmaceuticals Inc
SXTPAdicionar à lista de desejos
1.710USD
-0.040-2.29%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
1.75MValor de mercado
PerdaP/L TTM
Mais detalhes de 60 Degrees Pharmaceuticals Inc Empresa
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
Informações de 60 Degrees Pharmaceuticals Inc
Código da empresaSXTP
Nome da Empresa60 Degrees Pharmaceuticals Inc
Data de listagemJul 12, 2023
CEODow (Geoffrey S)
Número de funcionários3
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 12
Endereço1025 Connecticut Avenue Nw
CidadeWASHINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal20036
Telefone12023275422
Sitehttps://60degreespharma.com/
Código da empresaSXTP
Data de listagemJul 12, 2023
CEODow (Geoffrey S)
Executivos da empresa 60 Degrees Pharmaceuticals Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
59.00
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Perguntas frequentes
Quem são os cinco principais acionistas de 60 Degrees Pharmaceuticals Inc?
Os cinco principais acionistas de 60 Degrees Pharmaceuticals Inc são: Dr. Geoffrey S. Dow, Ph.D.
Quantas instituições possuem ações da 60 Degrees Pharmaceuticals Inc (SXTP)?
Em 2026Q1, 27 instituições possuíam ações da 60 Degrees Pharmaceuticals Inc, com valor de mercado aproximado de 228.38K, representando 8.66% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 141573.00.